Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Cinnamomum-Injeel Forte Liq (6d,12d,30d,200d/1.1ml) 6 D / 1.1 mL Liquid is a Health Canada–registered human drug (DIN 02058103) held by Biologische Heilmittel Heel GmbH, containing Cinnamomum Zeylanicum. Health Canada lists its status as Cancelled Post Market (status date 17 Jan 1997). Nexara Health has matched 1 registration of Cinnamomum Zeylanicum across 1 other regulated market.

Health Canada registration

DIN02058103
Brand nameCinnamomum-Injeel Forte Liq (6d,12d,30d,200d/1.1ml)
Active ingredientCinnamomum Zeylanicum
Strength6 D / 1.1 mL
Dosage formLiquid
RouteOral
CompanyBiologische Heilmittel Heel GmbH
StatusCancelled Post Market — 17 Jan 1997
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Cinnamomum Zeylanicum registered in other markets

1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
MalaysiaPis Kayu Maniz 400mg CapsuleProductive Intelligence ServicesNatural ProductPRODUCT APPROVEDNPRA

See every manufacturer of Cinnamomum Zeylanicum worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Cinnamomum-Injeel Forte Liq (6d,12d,30d,200d/1.1ml) (DIN 02058103) marketed in Canada?

No. Health Canada lists DIN 02058103 as Cancelled Post Market as of 17 Jan 1997.

Who holds the Canadian licence for this product?

Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.

Is Cinnamomum Zeylanicum registered outside Canada?

Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02058103, status date 1997-01-17; national medicine registries: NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02058103, status date 1997-01-17; national medicine registries: NPRA.

Health Canada Drug Product Database (DPD), DIN 02058103, status date 1997-01-17; national medicine registries: NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.